148 related articles for article (PubMed ID: 29189675)
1. Increasing Linezolid-resistant Enterococcus in a Children's Hospital.
Bagga B; Buckingham S; Arnold S; Nesbitt A; Guimera D; Lee K
Pediatr Infect Dis J; 2018 Mar; 37(3):242-244. PubMed ID: 29189675
[TBL] [Abstract][Full Text] [Related]
2. Investigation of mechanisms and molecular epidemiology of linezolid nonsusceptible Enterococcus faecalis isolated from a teaching hospital in China.
Li B; Ma CL; Yu X; Sun Y; Li MM; Ye JZ; Zhang YP; Wu Q; Zhou TL
J Microbiol Immunol Infect; 2016 Aug; 49(4):595-9. PubMed ID: 26210761
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program.
Flamm RK; Mendes RE; Hogan PA; Ross JE; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):283-9. PubMed ID: 25633420
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of hospital-acquired linezolid-nonsusceptible enterococci infection in Chongqing, China, 2011-2014.
Jia X; Ma W; Xu X; Yang S; Zhang L
Am J Infect Control; 2015 Dec; 43(12):e101-6. PubMed ID: 26315061
[TBL] [Abstract][Full Text] [Related]
5. Empyema thoracis caused by an optrA-positive and linezolid-intermediate Enterococcus faecalis strain.
Chien JY; Mendes RE; Deshpande LM; Hsueh PR
J Infect; 2017 Aug; 75(2):182-184. PubMed ID: 28506787
[No Abstract] [Full Text] [Related]
6. Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
Santayana EM; Grim SA; Janda WM; Layden JE; Lee TA; Clark NM
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):39-42. PubMed ID: 22749382
[TBL] [Abstract][Full Text] [Related]
7. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
[TBL] [Abstract][Full Text] [Related]
8. Detection of optrA-positive enterococci clinical isolates in Belgium.
Argudín MA; Youzaga S; Dodémont M; Heinrichs A; Roisin S; Deplano A; Nonhoff C; Hallin M
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):985-987. PubMed ID: 30771123
[No Abstract] [Full Text] [Related]
9. Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).
Papadimitriou-Olivgeris M; Kolonitsiou F; Zerva L; Lebessi E; Koutsia C; Drougka E; Sarrou S; Giormezis N; Vourli S; Doudoulakakis A; Konsolakis C; Marangos M; Anastassiou ED; Petinaki E; Spiliopoulou I
Diagn Microbiol Infect Dis; 2015 Dec; 83(4):386-8. PubMed ID: 26341703
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and antimicrobial susceptibility pattern of Enterococcus species isolated from different clinical samples at Black Lion Specialized Teaching Hospital, Addis Ababa, Ethiopia.
Ferede ZT; Tullu KD; Derese SG; Yeshanew AG
BMC Res Notes; 2018 Nov; 11(1):793. PubMed ID: 30400980
[TBL] [Abstract][Full Text] [Related]
11. Prolonged linezolid use is associated with the development of linezolid-resistant Enterococcus faecium.
Smith TT; Tamma PD; Do TB; Dzintars KE; Zhao Y; Cosgrove SE; Avdic E
Diagn Microbiol Infect Dis; 2018 Jun; 91(2):161-163. PubMed ID: 29496381
[TBL] [Abstract][Full Text] [Related]
12. Risk factors associated with linezolid-nonsusceptible enterococcal infections.
McGregor JC; Hartung DM; Allen GP; Taplitz RA; Traver R; Tong T; Bearden DT
Am J Infect Control; 2012 Nov; 40(9):886-7. PubMed ID: 22361358
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013).
Simner PJ; Adam H; Baxter M; McCracken M; Golding G; Karlowsky JA; Nichol K; Lagacé-Wiens P; Gilmour MW; ; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2015 Jul; 59(7):4315-7. PubMed ID: 25896693
[TBL] [Abstract][Full Text] [Related]
14. Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.
Bender JK; Fleige C; Klare I; Fiedler S; Mischnik A; Mutters NT; Dingle KE; Werner G
PLoS One; 2016; 11(11):e0167042. PubMed ID: 27893790
[TBL] [Abstract][Full Text] [Related]
15. Detection of the classical G2576U mutation in linezolid resistant Staphylococcus aureus along with isolation of linezolid resistant Enterococcus faecium from a patient on short-term linezolid therapy: first report from India.
Rai S; Niranjan DK; Kaur T; Singh NP; Hada V; Kaur IR
Indian J Med Microbiol; 2015; 33(1):21-4. PubMed ID: 25559997
[TBL] [Abstract][Full Text] [Related]
16. Co-infection with three linezolid-resistant Enterococcus faecium ST117 strain variants: what are we missing in diagnosis?
Freitas AR; Novais C; Read A; Alves V; Peixe L
Int J Antimicrob Agents; 2016 Jun; 47(6):500-1. PubMed ID: 27179813
[No Abstract] [Full Text] [Related]
17. Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China.
Wang L; He Y; Xia Y; Wang H; Liang S
Infect Genet Evol; 2014 Aug; 26():14-9. PubMed ID: 24815727
[TBL] [Abstract][Full Text] [Related]
18. Dose Optimization of Combined Linezolid and Fosfomycin against
Mao J; Li T; Zhang N; Wang S; Li Y; Peng Y; Liu H; Yang G; Yan Y; Jiang L; Liu Y; Li J; Huang X
Microbiol Spectr; 2021 Dec; 9(3):e0087121. PubMed ID: 34851157
[TBL] [Abstract][Full Text] [Related]
19. [Enterococci With Special Resistance Patterns - Epidemiology, Hygiene and Therapy].
Mischnik A; Werner G; Bender J; Mutters NT
Dtsch Med Wochenschr; 2019 Apr; 144(8):553-560. PubMed ID: 30986864
[TBL] [Abstract][Full Text] [Related]
20. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
